Impact of doxofylline in COPD: A pair-wise meta-analysis

Mario Cazzola, Luigino Calzetta, Paola Rogliani, Clive Page, Maria Gabriella Matera

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)
423 Downloads (Pure)

Abstract

Doxofylline is an effective bronchodilator for relieving airway obstruction in patients with asthma or chronic obstructive pulmonary disease (COPD), and displays a better safety profile with respect to theophylline. Herein, we performed a pair-wise meta-analysis of the currently available data to provide consistent and homogeneous findings on the impact of this xanthine in COPD patients. Results obtained from 820 patients were selected from 20 clinical trials. Meta-regression was performed to examine the source of heterogeneity between-studies and identify potential confounder covariates. The quality of the evidence was assessed by the GRADE system. Doxofylline induced a significant (P < 0.001) increase in forced expiratory volume in 1 s (FEV1) of 8.20% (95%CI 4.00–12.41; I2 93%) and 317 ml (95%CI 19–439; I2 87%) compared with baseline. The total administered dose of doxofylline significantly (P < 0.001) interacted with the size of the effect estimates detected for FEV1. Doxofylline induced a significant (P < 0.001), although moderate, increase in adverse events (AEs) frequency (proportion 0.03, 95%CI 0.02–0.04; I2 88%), but only epigastralgia, nausea, dyspepsia and headache were statistically significant (P < 0.05). The GRADE analysis indicated high quality of evidence (++++) for the impact of doxofylline on FEV1, and moderate quality of evidence (+++) for the safety profile in COPD patients. Doxofylline is an effective and safe medicine when administered to patients with COPD and can be considered as an alternative to theophylline.
Original languageEnglish
JournalPULMONARY PHARMACOLOGY AND THERAPEUTICS
Volume51
Early online date26 Apr 2018
DOIs
Publication statusE-pub ahead of print - 26 Apr 2018

Keywords

  • Doxofylline
  • Chronic obstructive pulmonary disease
  • Lung function
  • Safety
  • Pair-wise meta-analysis

Cite this